Jinxia Hu

2.1k total citations
74 papers, 1.6k citations indexed

About

Jinxia Hu is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Jinxia Hu has authored 74 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 16 papers in Cancer Research and 14 papers in Cell Biology. Recurrent topics in Jinxia Hu's work include Ubiquitin and proteasome pathways (7 papers), RNA modifications and cancer (7 papers) and MicroRNA in disease regulation (7 papers). Jinxia Hu is often cited by papers focused on Ubiquitin and proteasome pathways (7 papers), RNA modifications and cancer (7 papers) and MicroRNA in disease regulation (7 papers). Jinxia Hu collaborates with scholars based in China, United States and Macao. Jinxia Hu's co-authors include Guiyun Cui, Rutong Yu, Xiuping Zhou, Xinchun Ye, Lichun Xu, Qiong Shi, Wen‐Cheng Xiong, Lin Mei, Kun Zan and Zhihui Huang and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Jinxia Hu

69 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinxia Hu China 24 853 292 258 197 169 74 1.6k
Yongting Luo China 25 1.1k 1.2× 304 1.0× 132 0.5× 139 0.7× 359 2.1× 62 2.0k
Qingsong Wang China 25 1.4k 1.6× 345 1.2× 142 0.6× 137 0.7× 212 1.3× 67 1.9k
Wenjing Xu China 23 739 0.9× 173 0.6× 143 0.6× 64 0.3× 122 0.7× 76 1.8k
Ru‐Huei Fu Taiwan 27 996 1.2× 134 0.5× 250 1.0× 89 0.5× 115 0.7× 76 2.0k
Zhong‐Qin Liang China 31 1.5k 1.8× 518 1.8× 248 1.0× 151 0.8× 152 0.9× 68 2.6k
Baek‐Soo Han South Korea 24 2.2k 2.6× 163 0.6× 229 0.9× 146 0.7× 152 0.9× 52 3.2k
Jianhong Zhu China 30 1.4k 1.6× 368 1.3× 93 0.4× 301 1.5× 179 1.1× 78 2.5k
Huimei Yu China 26 1.2k 1.4× 329 1.1× 190 0.7× 67 0.3× 65 0.4× 65 2.0k
Natalia E. Abramova United States 8 903 1.1× 180 0.6× 144 0.6× 224 1.1× 77 0.5× 10 1.7k
María Gómez-Lázaro Portugal 22 693 0.8× 129 0.4× 94 0.4× 86 0.4× 164 1.0× 43 1.5k

Countries citing papers authored by Jinxia Hu

Since Specialization
Citations

This map shows the geographic impact of Jinxia Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinxia Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinxia Hu more than expected).

Fields of papers citing papers by Jinxia Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinxia Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinxia Hu. The network helps show where Jinxia Hu may publish in the future.

Co-authorship network of co-authors of Jinxia Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Jinxia Hu. A scholar is included among the top collaborators of Jinxia Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinxia Hu. Jinxia Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yiyang, Xingping Quan, Jinxia Hu, et al.. (2025). BMSCs-derived small extracellular vesicles antagonize cerebral endothelial Caveolin-1 driven autophagic degradation of tight-junction proteins to protect blood-brain barrier post-stroke. International Journal of Biological Sciences. 21(2). 842–859. 5 indexed citations
3.
Fu, Qiang, Jinxia Hu, Yang Jiao, et al.. (2025). mRNA vaccines in the context of cancer treatment: from concept to application. Journal of Translational Medicine. 23(1). 12–12. 11 indexed citations
4.
Li, Jianhong, Jing Xu, Jinxia Hu, et al.. (2025). PPARγ/β/δ Agonists Can Ameliorate Dextran Sodium Sulfate–Induced Colitis and Modulate Gut Microbiota. Journal of Gastroenterology and Hepatology. 40(6). 1536–1547. 3 indexed citations
5.
Hu, Jinxia, et al.. (2025). HSCCC-Tchebichef moment regression approach for enhanced quantification of oleuropein in olive leaf extracts. Journal of Chromatography A. 1763. 466445–466445.
6.
Xu, Jing, Jianhong Li, Chen-Tsung Huang, et al.. (2025). Secondary Bile Acids Modified by Odoribacter Splanchnicus Alleviate Colitis by Suppressing Neutrophil Extracellular Trap Formation. Advanced Science. 12(46). e09073–e09073.
7.
Wang, Zhuang, Jinxia Hu, Hongfang Sun, et al.. (2025). Oncogenic HNF4α inhibits ferroptotic cell death through activating SLC7A11 by recruiting p300/CBP in breast cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(6). 167884–167884.
8.
Yang, Zhen, Yun Yang, Jing Cong, et al.. (2024). NEDD1 Promotes the Development of Lung Adenocarcinoma and Can be Used as a Prognostic Marker. Journal of Cancer. 15(16). 5149–5164. 1 indexed citations
9.
Wang, Luwei, Hua Li, Ying Ma, et al.. (2024). MiR-383-5p inhibits the proliferation and migration of lung adenocarcinoma cells by targeting SHMT2. Journal of Cancer. 15(9). 2746–2758. 3 indexed citations
10.
Guo, Ruoyu, Jixia Li, Jinxia Hu, et al.. (2023). Combination of epidrugs with immune checkpoint inhibitors in cancer immunotherapy: From theory to therapy. International Immunopharmacology. 120. 110417–110417. 22 indexed citations
11.
Chen, Hao, et al.. (2023). Damage mechanism and therapy progress of the blood-brain barrier after ischemic stroke. Cell & Bioscience. 13(1). 196–196. 30 indexed citations
12.
Wang, Kaixuan, Hao Lu, Xinmiao Wang, et al.. (2023). Simultaneous suppression of PKM2 and PHGDH elicits synergistic anti-cancer effect in NSCLC. Frontiers in Pharmacology. 14. 1200538–1200538. 13 indexed citations
13.
Hu, Jinxia, Yanmei Li, Ranran Wang, et al.. (2021). RFWD2 Knockdown as a Blocker to Reverse the Oncogenic Role of TRIB2 in Lung Adenocarcinoma. Frontiers in Oncology. 11. 733175–733175. 4 indexed citations
14.
Yao, Lingling, Jinxia Hu, Qiang Li, et al.. (2020). Astrocytic neogenin/netrin-1 pathway promotes blood vessel homeostasis and function in mouse cortex. Journal of Clinical Investigation. 130(12). 6490–6509. 26 indexed citations
15.
Chen, Minmin, Jinxia Hu, Lujing Wang, et al.. (2020). Targeted and redox-responsive drug delivery systems based on carbonic anhydrase IX-decorated mesoporous silica nanoparticles for cancer therapy. Scientific Reports. 10(1). 14447–14447. 68 indexed citations
16.
Zhang, Yanxia, Yunfei Yan, Youjie Li, et al.. (2016). Smad3-related miRNAs regulated oncogenic TRIB2 promoter activity to effectively suppress lung adenocarcinoma growth. Cell Death and Disease. 7(12). e2528–e2528. 30 indexed citations
17.
Hu, Jinxia, Qiuchen Zhao, Peisheng Jin, et al.. (2016). Bone marrow stromal cells inhibits HMGB1-mediated inflammation after stroke in type 2 diabetic rats. Neuroscience. 324. 11–19. 27 indexed citations
18.
Huang, Zhihui, Dong Sun, Jinxia Hu, et al.. (2016). Neogenin Promotes BMP2 Activation of YAP and Smad1 and Enhances Astrocytic Differentiation in Developing Mouse Neocortex. Journal of Neuroscience. 36(21). 5833–5849. 50 indexed citations
19.
Yang, Yan, Jinxia Hu, Yanfang Liu, et al.. (2011). Antioxidant and Cytotoxic Activities of Ethanolic Extracts and Isolated Fractions of Species of the Genus Phellinus Quél. (Aphyllophoromycetideae). International journal of medicinal mushrooms. 13(2). 145–152. 6 indexed citations
20.
Liu, Lu, Jinxia Hu, He Wang, et al.. (2010). Effects of beta-cypermethrin on male rat reproductive system. Environmental Toxicology and Pharmacology. 30(3). 251–256. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026